Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Substrate SARs in human P450s.

David F V Lewis1, Maurice Dickins

  • 1School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey, UK GU2 7XH. d.lewis@surrey.ac.uk

Drug Discovery Today
|January 28, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and application of a PBPK modeling strategy to support antimalarial drug development.

CPT: pharmacometrics & systems pharmacology·2023
Same author

An in vitro toolbox to accelerate anti-malarial drug discovery and development.

Malaria journal·2020
Same author

Molecular Binding Interactions: Their Estimation and Rationalization in QSARs in Terms of Theoretically Derived Parameters.

TheScientificWorldJournal·2018
Same author

Metal toxicity in two rodent species and redox potential: Evaluation of quantitative structure-activity relationships.

Environmental toxicology and chemistry·2018
Same author

Risk-Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling Approach.

Clinical pharmacology and therapeutics·2018
Same author

Classification Models for Predicting Cytochrome P450 Enzyme-Substrate Selectivity.

Molecular informatics·2016
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026
See all related articles

Understanding drug metabolism is key in drug discovery. Key properties like lipophilicity and molecular mass of cytochrome P450 (CYP) substrates influence their selectivity and binding affinity to specific CYP enzymes.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Medicinal Chemistry

Background:

  • Drug metabolism is crucial in drug discovery and development.
  • Cytochromes P450 (CYPs) are the primary enzyme family responsible for human drug metabolism.
  • Understanding substrate properties is essential for predicting drug interactions and efficacy.

Purpose of the Study:

  • To elucidate the relationship between physicochemical properties of CYP substrates and their selectivity.
  • To explain the variations in binding affinities of human CYP substrates.
  • To provide insights into substrate recognition by major human CYP isozymes.

Main Methods:

  • Analysis of key characteristics of 60 human CYP substrates.
  • Evaluation of lipophilicity, molecular mass, and hydrogen-bonding potential.

Related Experiment Videos

  • Correlation of physicochemical properties with substrate binding affinities.

    • Main Results:

    • Specific substrate properties, including lipophilicity, molecular mass, and hydrogen-bonding potential, were identified as key determinants of CYP selectivity.
    • The observed variations in binding affinities across different CYP isozymes can be attributed to these physicochemical, structural, and electronic characteristics.
    • A comprehensive understanding of these factors allows for prediction of substrate interactions with individual CYPs.

    Conclusions:

    • Physicochemical properties of drug candidates significantly influence their metabolism by cytochromes P450.
    • Understanding these properties is vital for optimizing drug design and minimizing adverse drug reactions.
    • This knowledge aids in the rational selection of drug candidates with desired metabolic profiles.